2020
DOI: 10.33029/2305-3496-2020-9-3-79-86
|View full text |Cite
|
Sign up to set email alerts
|

Glucosaminyl muramy ldipeptide in treatment and prevention of infectious diseases

Abstract: Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук, 117997, г. Москва, Российская Федерация 2 Медицинский институт, Федеральное государственное автономное образовательное учреждение высшего образования «Российский университет дружбы народов», 117198, г. Москва, Российская Федерация 3 Федеральное государственное бюджетное учреждение «Государственный научный центр «Институт иммунологии» Федерального медико… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 3 publications
2
1
0
Order By: Relevance
“…For the first time, the study covers a large group of participants with moderate physical activity, who used Licopid for prophylaxis. This clinical observation is consistent with the previously obtained results of the positive effect of GMDP in the prevention of acute respiratory infections in children and adults [14, 15,52].…”
Section: Tablesupporting
confidence: 93%
See 1 more Smart Citation
“…For the first time, the study covers a large group of participants with moderate physical activity, who used Licopid for prophylaxis. This clinical observation is consistent with the previously obtained results of the positive effect of GMDP in the prevention of acute respiratory infections in children and adults [14, 15,52].…”
Section: Tablesupporting
confidence: 93%
“…The maximum number of episodes of acute respiratory infections in the group of athletes in comparison with athletes of other sports indicates the tension of mucosal immunity and a decrease in the adaptive capabilities of the organism. A 7-fold reduction in this group of ARI episodes when taking GMDP confirms its effectiveness in increasing the body's resistance to acute viral infections of the respiratory tract, previously established for children and adults [52].…”
Section: Tablesupporting
confidence: 80%
“…Muramyl peptides are included in the structure of the cell wall of all known bacteria and implement their biological activity through specific binding to NOD2 receptors of innate immunity related to NLR [21]. Muramyl peptides, acting on cells of the immune system and epitheliocytes, stimulates production of cytokines, immunoglobulins and defensins, changes the phenotype of immunocompetent cells [22][23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%